BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villar-Hernández R, Latorre I, Mínguez S, Díaz J, García-García E, Muriel-Moreno B, Lacoma A, Prat C, Olivé A, Ruhwald M, Mateo L, Domínguez J. Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases. J Infect 2017;75:315-25. [PMID: 28751171 DOI: 10.1016/j.jinf.2017.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Domínguez J, Latorre I, Santin M. Diagnosis and therapeutic approach of latent tuberculosis infection. Enfermedades infecciosas y microbiologia clinica (English ed ) 2018;36:302-11. [DOI: 10.1016/j.eimce.2017.11.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Qiu X, Tang Y, Zou R, Zeng Y, Yue Y, Li W, Qu Y, Mu D. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis. Sci Rep 2019;9:11408. [PMID: 31388072 DOI: 10.1038/s41598-019-47923-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Villar-Hernández R, Latorre I, De Souza-Galvão ML, Jiménez MA, Ruiz-Manzano J, Pilarte J, García-García E, Muriel-Moreno B, Cantos A, Altet N, Millet JP, González-Díaz Y, Molina-Pinargote I, Prat C, Ruhwald M, Domínguez J. Use of IP-10 detection in dried plasma spots for latent tuberculosis infection diagnosis in contacts via mail. Sci Rep 2019;9:3943. [PMID: 30850687 DOI: 10.1038/s41598-019-40778-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Comella-Del-Barrio P, Abellana R, Villar-Hernández R, Jean Coute MD, Sallés Mingels B, Canales Aliaga L, Narcisse M, Gautier J, Ascaso C, Latorre I, Dominguez J, Perez-Porcuna TM. A Model Based on the Combination of IFN-γ, IP-10, Ferritin and 25-Hydroxyvitamin D for Discriminating Latent From Active Tuberculosis in Children. Front Microbiol 2019;10:1855. [PMID: 31474956 DOI: 10.3389/fmicb.2019.01855] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Blauenfeldt T, Villar-Hernández R, García-García E, Latorre I, Holm LL, Muriel-Moreno B, De Souza-Galvão ML, Millet JP, Sabriá F, Sánchez-Montalva A, Ruiz-Manzano J, Pilarte J, Jiménez MA, Centeno C, Torres C, Molina-Pinargote I, González-Díaz YD, Santiago J, Cantos A, Prat C, Andersen P, Domínguez J, Ruhwald M. Diagnostic Accuracy of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Tuberculosis. J Clin Microbiol 2020;58:e00848-20. [PMID: 32719030 DOI: 10.1128/JCM.00848-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Latorre I, Mínguez S, Carrascosa JM, Naves J, Villar-Hernández R, Muriel B, Prat C, García-García E, Casas I, Domènech E, Ferrándiz C, Mateo L, Domínguez J. Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice. PLoS One 2017;12:e0189202. [PMID: 29216277 DOI: 10.1371/journal.pone.0189202] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
7 Petrone L, Vanini V, Chiacchio T, Petruccioli E, Cuzzi G, Schininà V, Palmieri F, Ippolito G, Goletti D. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb) 2018;111:147-53. [PMID: 30029901 DOI: 10.1016/j.tube.2018.06.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
8 Domínguez J, Latorre I, Santin M. Diagnóstico y abordaje terapéutico de la infección tuberculosa latente. Enfermedades Infecciosas y Microbiología Clínica 2018;36:302-11. [DOI: 10.1016/j.eimc.2017.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Carrère-kremer S, Kolia-diafouka P, Pisoni A, Bolloré K, Peries M, Godreuil S, Bourdin A, Van de Perre P, Tuaillon E. QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG. Front Microbiol 2022;13:825021. [DOI: 10.3389/fmicb.2022.825021] [Reference Citation Analysis]